You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 2, February 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Immunologic Disorders
 •Alert me on articles by topic

Using Molecular Biologic Analysis of T-Cell Receptor Gene Rearrangements to Stage Cutaneous T-Cell Lymphoma

Arch Dermatol. 1998;134:221-223.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IT WAS the mid-1980s when the first wave of molecular biologic analysis of T-cell receptor (TCR) gene rearrangements was applied to cutaneous T-cell lymphoma (CTCL), ie, mycosis fungoides and its leukemic variant, the Sézary syndrome.1 Initial studies involved genomic Southern blot analysis and demonstrated 2 important features: (1) each individual lesion of CTCL contained a dominant T-cell clone, and (2) multiple lesions from individual patients contained the same dominant T-cell clone in all sites of disease. These findings established that, like other forms of lymphoma, CTCL is typically a monoclonal lymphoproliferative disorder. They also formed the basis for many subsequent studies during the next decade that confirmed that the detection of monoclonal TCR gene rearrangements is a useful molecular biologic adjunct to the clinicopathologic diagnosis of this neoplasm. These more recent studies involved not only conventional genomic Southern blotting but also more sensitive clonality assays using polymerase chain . . . [Full Text of this Article]


RELATED ARTICLE

Analysis of T-Cell Receptor Gene Rearrangement in Lymph Nodes of Patients With Mycosis Fungoides: Prognostic Implications
Donald E. Kern, Pamela G. Kidd, Roger Moe, Deena Hanke, and John E. Olerud
Arch Dermatol. 1998;134(2):158-164.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early TCR-{beta} and TCR-{gamma} PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications
Assaf et al.
Blood 2005;105:503-510.
ABSTRACT | FULL TEXT  

Clonal heterogeneity in mycosis fungoides and its relationship to clinical course
Vega et al.
Blood 2002;100:3369-3373.
ABSTRACT | FULL TEXT  

An Update on Treating Cutaneous T-Cell Lymphoma
Journal Watch Dermatology 1999;1999:10-10.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.